CellMed 2024; 14(7): 2.1-2.4
Published online May 31, 2024
https://doi.org/10.5667/CellMed.spc.081
© Cellmed Orthocellular Medicine and Pharmaceutical Association
조종빈 약사
전라남도 화순군 화순읍 자치샘로 42-2 셀메드 화순 종로약국
Correspondence to : Jong-Bin Jo
E-mail: jongro3720178@hanmail.net
☨ This report has been translated and edited by the CellMed editor-in-chief, Prof. Beom-Jin Lee.
This is an open access article under the CC BY-NC license. (http://creativecommons.org/licenses/by-nc/3.0/)
Objective: A study on the improvement of infertility using Ortho-Cellular Nutrition Therapy.
Methods: OCNT was administered to a 36-year-old Korean woman experiencing infertility symptoms.
Results: After administering OCNT, infertility symptoms improved, and the patient successfully conceived through in vitro fertilization.
Conclusion: The application of OCNT can assist patients experiencing infertility symptoms.
Keywords Ortho-Cellular Nutrition Therapy (OCNT), infertility, ovarian function decline, in vitro fertilization
A woman's ovaries, located on both sides of the uterus, produce eggs and supply female hormones such as estrogen and progesterone. The ovaries become active during puberty and play a crucial role in successful conception during the reproductive years, but their function declines after the late 30s.
Infertility is defined as the inability to conceive after one year of regular, unprotected intercourse during the fertile phase of the menstrual cycle.1 Direct causes include tubal dysfunction, ovulatory dysfunction due to decreased ovarian function (premature menopause), endometrial dysfunction, cervical dysfunction, and uterine fibroids, among others.2
Decreased ovarian function means a reduction in the number of remaining pre-egg cells in the ovaries and can result from genetic defects, chemotherapy or radiation treatment, surgery, etc.3 Since ovarian function is challenging to restore once it declines, evaluating and managing ovarian function is crucial for conception. This evaluation requires blood tests and ultrasound examinations.
Blood tests measure hormone levels, including follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), and anti-Müllerian hormone (AMH), which are necessary to assess ovarian function. Among these, AMH plays a crucial role in measuring the quantity of eggs.4 Ultrasound examinations are critical indicators for evaluating functional ovarian reserves by measuring the number of follicles in the ovaries, and a combined total of seven or fewer eggs in both ovaries may indicate decreased ovarian function.5 Mild decreased ovarian function may increase natural pregnancy rates through ovulation induction agents, while severe cases or advanced age may require artificial insemination or in vitro fertilization (IVF) to induce pregnancy.
In vitro fertilization-embryo transfer (IVF-ET) is a type of assisted reproductive technology that involves fertilizing sperm and eggs outside the body, culturing them in a test tube for 2-5 days, and then implanting them into the uterus. This procedure is performed for various reasons, such as blocked or damaged fallopian tubes, uterine issues like endometriosis or fibroids, multiple causes of ovarian failure, failed artificial insemination attempts, and unexplained infertility. The IVF-ET process includes ovulation induction through hormone medication, egg and sperm retrieval using micro-needles, in vitro fertilization and embryo culture, embryo transfer, endometrial support, and blood tests to confirm pregnancy.6
This case report presents a patient who successfully conceived after receiving OCNT for infertility, with the patient's consent.
This study focused on one infertility patient.
1) Name: Ahn ○○ (F/36 years old)
2) Diagnosis: Infertility
3) Date of Onset: July 2021
4) Treatment Duration: April 2022 ~ March 2023
5) Primary Symptoms: Infertility, anxiety, insomnia, fatigue
6) Medical History: Multiple failed infertility treatments
7) Social History: None
8) Family History: None
9) Medications and Treatments Applied: Haloxin, Solondo, antirheumatic drug injections (for rheumatoid arthritis in the fingers), Synthroid 0.1mg (for hypothyroidism)
Table 1 shows the OCNT prescribed to the patient and her husband, along with the details of their intake. The prescribed OCNT was maintained until delivery, and a strict diet excluding flour and dairy products was followed during the intake period.
Table 1 . OCNT Prescription Details for Nutrition Therapy
Type / Month | 1st Month | 2nd Month | 3rd Month | 4th Month | 5th Month | 6th Month | 7th Month |
---|---|---|---|---|---|---|---|
Patient OCNT | |||||||
Cyaplex X granule | 101 | 101 | 101 | 101 | 101 | 101 | 101 |
Eufaplex alpha stick | 101 | 101 | 101 | 101 | 101 | 101 | 101 |
Tmplex granule | 101 | 101 | 101 | 101 | 101 | 101 | 101 |
Nutaplex granule | 101 | 101 | - | ||||
Bioplex F granule | 101 | 101 | 101 | 101 | 101 | 101 | 101 |
Angelan F granule | 101 | 101 | 101 | 101 | 101 | 101 | - |
Hemoplex capsule | - | 202 | 202 | 202 | 202 | 202 | |
Diverol capsule | - | 101 | 101 | 101 | 101 | 101 | |
Sulfoplex PK tablet | - | 202 | 202 | 202 | |||
Husband OCNT | |||||||
Cyaplex X granule | 101 | 101 | 101 | 101 | - | ||
Eufaplex alpha capsule | 303 | 303 | 303 | 303 | - | ||
Tmplex capsule | 101 | 101 | 101 | 101 | - | ||
Bioplex F granule | 101 | 101 | 101 | 101 | - |
* 101: Take 1 capsule/packet twice daily. 202: Take 2 capsules/packets twice daily. 303: Take 3 capsules/packets twice daily.
One month after applying OCNT, the previously black menstrual blood returned to a normal color. Two months later, two healthy eggs were successfully harvested and frozen after five days of incubation. Three months later, the endometrium reached 9mm, and an implantation attempt was made in the fourth month. Subsequently, an HCG hormone level of 430mlU/ml, which is indicative of 4-5 weeks of pregnancy, was confirmed, and the successful establishment of the gestational sac was observed shortly after.
After confirming the pregnancy, the patient discontinued antirheumatic drug injections for rheumatoid arthritis in the fingers and gradually reduced the dosage of oral medications. Additionally, symptoms such as fatigue, insomnia, and anxiety, which had arisen due to infertility, gradually improved with the continuation of OCNT. These measurements are shown in Table 2.
Table 2 . Degree of Symptoms Felt by the Patient During OCNT.
Symptom / Month | 1st Month | 2nd Month | 3rd Month | 4th Month | 5th Month | 6th Month | 7th Month |
---|---|---|---|---|---|---|---|
Fatigue | 4 | 2 | 2 | 1 | 1 | 1 | 1 |
Insomnia | 3 | 2 | 1 | 1 | 1 | 1 | 0 |
Anxiety/Nervousness | 3 | 2 | 1 | 1 | 0 | 0 | 0 |
Remarks | Secured 2 healthy eggs | 9mm endometrium secured | HCG 430 and pregnancy confirmed | Successful IVF |
0: No symptoms, 1: Mild symptoms, daily life is possible, 2: Slight discomfort in daily life, 3: Symptoms significantly affect daily life, some activities are uncomfortable, 4: Difficulty performing activities in daily life, 5: Severe discomfort, unable to perform daily activities.
The subject of this case study is a 36-year-old woman in her third year of marriage who received treatments at a Korean medicine clinic and an obstetrics and gynecology clinic to address her infertility. Despite these efforts, she continued to struggle with conception, and starting in July 2021, she underwent three rounds of in vitro fertilization at an infertility clinic, all of which failed due to poor quality of both eggs and sperm, leading her to experience anxiety and restlessness. Her husband also recognized the poor quality of his sperm, prompting both partners to undertake infertility OCNT together.
In the process of conception and pregnancy, which marks the beginning of new life, the maturity of sperm and eggs and the quality of the gestational sac are crucial. The role of follicles is significant in producing mature eggs. Thus, various OCNTs were applied to create an intrauterine environment conducive to generating sperm, eggs, and a healthy gestational sac.
To create a healthy pregnancy environment, it is essential to reduce oxidative stress that induces cell proliferation inhibition or increased apoptosis, lower infertility risks, and supplement nutrients that positively affect fertility.7 Anthocyanins, supplied through Cyaplex X, play an excellent role in reducing oxidative stress8. Additionally, the heme iron in Hemoplex is known to decrease infertility risks, while vitamins B and folic acid significantly affect fertility.9,10 Chlorella, which is excellent for enhancing and regulating immune capacity,11 and Angelan, an extract of Angelica,12 were supplied through Nutaplex and Angelan F, respectively, along with probiotics and prebiotics through Bioplex to establish a healthy intrauterine environment.13 Lastly, in the husband's case, zinc supplied through Tmplex helped improve male fertility, laying the foundation for obtaining high-quality sperm.14 These OCNTs enabled the case study patient and her husband to obtain healthy, high-quality eggs and sperm.
The patient was psychologically anxious due to concerns about late pregnancy and was receiving injection and drug therapy for rheumatoid arthritis and hypothyroidism. Despite counseling aimed at inducing natural pregnancy, she desired an IVF due to her health status. Additionally, due to concerns about miscarriage and the inability to stop her medications, she wished to continue OCNT after pregnancy.
Numerous studies reports that individuals who consume omega-6, linoleic acid, and vitamin D have higher success rates with IVF.15,16 Therefore, it is believed that these nutrients supplied through Eufaplex alpha and Diverol contributed to the success of the IVF process and alleviated the patient's anxiety.
Selenium and iodine in Tmplex are essential trace nutrients for increasing thyroid hormone production17,18 and Methylsulfonylmethane (MSM), one of the main components of Sulfoplex, can significantly improve pain related to arthritis and help protect cartilage.19 It is assumed that these OCNTs made it possible to reduce the treatments and medications the patient was receiving for osteoarthritis and hypothyroidism.
This case study is limited to a single patient, and therefore cannot be generalized to all infertility patients. However, it is meaningful to report with the patient's consent that appropriate application of OCNT improved her infertility and led to a successful pregnancy.
CellMed 2024; 14(7): 2.1-2.4
Published online May 31, 2024 https://doi.org/10.5667/CellMed.spc.081
Copyright © Cellmed Orthocellular Medicine and Pharmaceutical Association.
조종빈 약사
전라남도 화순군 화순읍 자치샘로 42-2 셀메드 화순 종로약국
Pharmacist, Jong-Bin Jo
Cellmed Hwasun Jongro Pharmacy, 42-2, Jachisam-ro, Hwasun-eup, Hwasun-gun, Jeonllanam-do, Republic of Korea
Correspondence to:Jong-Bin Jo
E-mail: jongro3720178@hanmail.net
☨ This report has been translated and edited by the CellMed editor-in-chief, Prof. Beom-Jin Lee.
This is an open access article under the CC BY-NC license. (http://creativecommons.org/licenses/by-nc/3.0/)
Objective: A study on the improvement of infertility using Ortho-Cellular Nutrition Therapy.
Methods: OCNT was administered to a 36-year-old Korean woman experiencing infertility symptoms.
Results: After administering OCNT, infertility symptoms improved, and the patient successfully conceived through in vitro fertilization.
Conclusion: The application of OCNT can assist patients experiencing infertility symptoms.
Keywords: Ortho-Cellular Nutrition Therapy (OCNT), infertility, ovarian function decline, in vitro fertilization
A woman's ovaries, located on both sides of the uterus, produce eggs and supply female hormones such as estrogen and progesterone. The ovaries become active during puberty and play a crucial role in successful conception during the reproductive years, but their function declines after the late 30s.
Infertility is defined as the inability to conceive after one year of regular, unprotected intercourse during the fertile phase of the menstrual cycle.1 Direct causes include tubal dysfunction, ovulatory dysfunction due to decreased ovarian function (premature menopause), endometrial dysfunction, cervical dysfunction, and uterine fibroids, among others.2
Decreased ovarian function means a reduction in the number of remaining pre-egg cells in the ovaries and can result from genetic defects, chemotherapy or radiation treatment, surgery, etc.3 Since ovarian function is challenging to restore once it declines, evaluating and managing ovarian function is crucial for conception. This evaluation requires blood tests and ultrasound examinations.
Blood tests measure hormone levels, including follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), and anti-Müllerian hormone (AMH), which are necessary to assess ovarian function. Among these, AMH plays a crucial role in measuring the quantity of eggs.4 Ultrasound examinations are critical indicators for evaluating functional ovarian reserves by measuring the number of follicles in the ovaries, and a combined total of seven or fewer eggs in both ovaries may indicate decreased ovarian function.5 Mild decreased ovarian function may increase natural pregnancy rates through ovulation induction agents, while severe cases or advanced age may require artificial insemination or in vitro fertilization (IVF) to induce pregnancy.
In vitro fertilization-embryo transfer (IVF-ET) is a type of assisted reproductive technology that involves fertilizing sperm and eggs outside the body, culturing them in a test tube for 2-5 days, and then implanting them into the uterus. This procedure is performed for various reasons, such as blocked or damaged fallopian tubes, uterine issues like endometriosis or fibroids, multiple causes of ovarian failure, failed artificial insemination attempts, and unexplained infertility. The IVF-ET process includes ovulation induction through hormone medication, egg and sperm retrieval using micro-needles, in vitro fertilization and embryo culture, embryo transfer, endometrial support, and blood tests to confirm pregnancy.6
This case report presents a patient who successfully conceived after receiving OCNT for infertility, with the patient's consent.
This study focused on one infertility patient.
1) Name: Ahn ○○ (F/36 years old)
2) Diagnosis: Infertility
3) Date of Onset: July 2021
4) Treatment Duration: April 2022 ~ March 2023
5) Primary Symptoms: Infertility, anxiety, insomnia, fatigue
6) Medical History: Multiple failed infertility treatments
7) Social History: None
8) Family History: None
9) Medications and Treatments Applied: Haloxin, Solondo, antirheumatic drug injections (for rheumatoid arthritis in the fingers), Synthroid 0.1mg (for hypothyroidism)
Table 1 shows the OCNT prescribed to the patient and her husband, along with the details of their intake. The prescribed OCNT was maintained until delivery, and a strict diet excluding flour and dairy products was followed during the intake period.
Table 1 . OCNT Prescription Details for Nutrition Therapy.
Type / Month | 1st Month | 2nd Month | 3rd Month | 4th Month | 5th Month | 6th Month | 7th Month |
---|---|---|---|---|---|---|---|
Patient OCNT | |||||||
Cyaplex X granule | 101 | 101 | 101 | 101 | 101 | 101 | 101 |
Eufaplex alpha stick | 101 | 101 | 101 | 101 | 101 | 101 | 101 |
Tmplex granule | 101 | 101 | 101 | 101 | 101 | 101 | 101 |
Nutaplex granule | 101 | 101 | - | ||||
Bioplex F granule | 101 | 101 | 101 | 101 | 101 | 101 | 101 |
Angelan F granule | 101 | 101 | 101 | 101 | 101 | 101 | - |
Hemoplex capsule | - | 202 | 202 | 202 | 202 | 202 | |
Diverol capsule | - | 101 | 101 | 101 | 101 | 101 | |
Sulfoplex PK tablet | - | 202 | 202 | 202 | |||
Husband OCNT | |||||||
Cyaplex X granule | 101 | 101 | 101 | 101 | - | ||
Eufaplex alpha capsule | 303 | 303 | 303 | 303 | - | ||
Tmplex capsule | 101 | 101 | 101 | 101 | - | ||
Bioplex F granule | 101 | 101 | 101 | 101 | - |
* 101: Take 1 capsule/packet twice daily. 202: Take 2 capsules/packets twice daily. 303: Take 3 capsules/packets twice daily..
One month after applying OCNT, the previously black menstrual blood returned to a normal color. Two months later, two healthy eggs were successfully harvested and frozen after five days of incubation. Three months later, the endometrium reached 9mm, and an implantation attempt was made in the fourth month. Subsequently, an HCG hormone level of 430mlU/ml, which is indicative of 4-5 weeks of pregnancy, was confirmed, and the successful establishment of the gestational sac was observed shortly after.
After confirming the pregnancy, the patient discontinued antirheumatic drug injections for rheumatoid arthritis in the fingers and gradually reduced the dosage of oral medications. Additionally, symptoms such as fatigue, insomnia, and anxiety, which had arisen due to infertility, gradually improved with the continuation of OCNT. These measurements are shown in Table 2.
Table 2 . Degree of Symptoms Felt by the Patient During OCNT..
Symptom / Month | 1st Month | 2nd Month | 3rd Month | 4th Month | 5th Month | 6th Month | 7th Month |
---|---|---|---|---|---|---|---|
Fatigue | 4 | 2 | 2 | 1 | 1 | 1 | 1 |
Insomnia | 3 | 2 | 1 | 1 | 1 | 1 | 0 |
Anxiety/Nervousness | 3 | 2 | 1 | 1 | 0 | 0 | 0 |
Remarks | Secured 2 healthy eggs | 9mm endometrium secured | HCG 430 and pregnancy confirmed | Successful IVF |
0: No symptoms, 1: Mild symptoms, daily life is possible, 2: Slight discomfort in daily life, 3: Symptoms significantly affect daily life, some activities are uncomfortable, 4: Difficulty performing activities in daily life, 5: Severe discomfort, unable to perform daily activities..
The subject of this case study is a 36-year-old woman in her third year of marriage who received treatments at a Korean medicine clinic and an obstetrics and gynecology clinic to address her infertility. Despite these efforts, she continued to struggle with conception, and starting in July 2021, she underwent three rounds of in vitro fertilization at an infertility clinic, all of which failed due to poor quality of both eggs and sperm, leading her to experience anxiety and restlessness. Her husband also recognized the poor quality of his sperm, prompting both partners to undertake infertility OCNT together.
In the process of conception and pregnancy, which marks the beginning of new life, the maturity of sperm and eggs and the quality of the gestational sac are crucial. The role of follicles is significant in producing mature eggs. Thus, various OCNTs were applied to create an intrauterine environment conducive to generating sperm, eggs, and a healthy gestational sac.
To create a healthy pregnancy environment, it is essential to reduce oxidative stress that induces cell proliferation inhibition or increased apoptosis, lower infertility risks, and supplement nutrients that positively affect fertility.7 Anthocyanins, supplied through Cyaplex X, play an excellent role in reducing oxidative stress8. Additionally, the heme iron in Hemoplex is known to decrease infertility risks, while vitamins B and folic acid significantly affect fertility.9,10 Chlorella, which is excellent for enhancing and regulating immune capacity,11 and Angelan, an extract of Angelica,12 were supplied through Nutaplex and Angelan F, respectively, along with probiotics and prebiotics through Bioplex to establish a healthy intrauterine environment.13 Lastly, in the husband's case, zinc supplied through Tmplex helped improve male fertility, laying the foundation for obtaining high-quality sperm.14 These OCNTs enabled the case study patient and her husband to obtain healthy, high-quality eggs and sperm.
The patient was psychologically anxious due to concerns about late pregnancy and was receiving injection and drug therapy for rheumatoid arthritis and hypothyroidism. Despite counseling aimed at inducing natural pregnancy, she desired an IVF due to her health status. Additionally, due to concerns about miscarriage and the inability to stop her medications, she wished to continue OCNT after pregnancy.
Numerous studies reports that individuals who consume omega-6, linoleic acid, and vitamin D have higher success rates with IVF.15,16 Therefore, it is believed that these nutrients supplied through Eufaplex alpha and Diverol contributed to the success of the IVF process and alleviated the patient's anxiety.
Selenium and iodine in Tmplex are essential trace nutrients for increasing thyroid hormone production17,18 and Methylsulfonylmethane (MSM), one of the main components of Sulfoplex, can significantly improve pain related to arthritis and help protect cartilage.19 It is assumed that these OCNTs made it possible to reduce the treatments and medications the patient was receiving for osteoarthritis and hypothyroidism.
This case study is limited to a single patient, and therefore cannot be generalized to all infertility patients. However, it is meaningful to report with the patient's consent that appropriate application of OCNT improved her infertility and led to a successful pregnancy.
Table 1 . OCNT Prescription Details for Nutrition Therapy.
Type / Month | 1st Month | 2nd Month | 3rd Month | 4th Month | 5th Month | 6th Month | 7th Month |
---|---|---|---|---|---|---|---|
Patient OCNT | |||||||
Cyaplex X granule | 101 | 101 | 101 | 101 | 101 | 101 | 101 |
Eufaplex alpha stick | 101 | 101 | 101 | 101 | 101 | 101 | 101 |
Tmplex granule | 101 | 101 | 101 | 101 | 101 | 101 | 101 |
Nutaplex granule | 101 | 101 | - | ||||
Bioplex F granule | 101 | 101 | 101 | 101 | 101 | 101 | 101 |
Angelan F granule | 101 | 101 | 101 | 101 | 101 | 101 | - |
Hemoplex capsule | - | 202 | 202 | 202 | 202 | 202 | |
Diverol capsule | - | 101 | 101 | 101 | 101 | 101 | |
Sulfoplex PK tablet | - | 202 | 202 | 202 | |||
Husband OCNT | |||||||
Cyaplex X granule | 101 | 101 | 101 | 101 | - | ||
Eufaplex alpha capsule | 303 | 303 | 303 | 303 | - | ||
Tmplex capsule | 101 | 101 | 101 | 101 | - | ||
Bioplex F granule | 101 | 101 | 101 | 101 | - |
* 101: Take 1 capsule/packet twice daily. 202: Take 2 capsules/packets twice daily. 303: Take 3 capsules/packets twice daily..
Table 2 . Degree of Symptoms Felt by the Patient During OCNT..
Symptom / Month | 1st Month | 2nd Month | 3rd Month | 4th Month | 5th Month | 6th Month | 7th Month |
---|---|---|---|---|---|---|---|
Fatigue | 4 | 2 | 2 | 1 | 1 | 1 | 1 |
Insomnia | 3 | 2 | 1 | 1 | 1 | 1 | 0 |
Anxiety/Nervousness | 3 | 2 | 1 | 1 | 0 | 0 | 0 |
Remarks | Secured 2 healthy eggs | 9mm endometrium secured | HCG 430 and pregnancy confirmed | Successful IVF |
0: No symptoms, 1: Mild symptoms, daily life is possible, 2: Slight discomfort in daily life, 3: Symptoms significantly affect daily life, some activities are uncomfortable, 4: Difficulty performing activities in daily life, 5: Severe discomfort, unable to perform daily activities..
Pharmacist, Neung su Cheon
CellMed 2023; 13(13): 4.1-4.5Pharmacist, Ayoung Lee
CellMed 2024; 14(16): 3.1-3.4Pharmacist, Mijin Kim
CellMed 2024; 14(16): 2.1-2.3